Elevated levels of interleukin-27 in patients with Sjogren's syndrome

被引：13
|
作者：
Xia, L. [1 ]
Shen, H. [1 ]
Zhao, L. [1 ]
Lu, J. [1 ]
机构：
[1] China Med Univ, Dept Rheumatol, Affiliated Hosp 1, Shenyang 110001, Peoples R China
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2012年 / 41卷 / 01期
关键词：
SALIVARY-GLANDS; T-CELLS;
D O I：
10.3109/03009742.2011.620574
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [31] Serum interleukin-17 & nitric oxide levels in patients with primary Sjogren's syndrome
    Miletic, M.
    Stojanovic, R.
    Pajic, O.
    Bugarski, D.
    Mojsilovic, S.
    Cokic, V.
    Milenkovic, P.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2012, 135 (04) : 513 - 519
  • [32] Serum levels of interleukin-34 and clinical correlation in patients with primary Sjogren's syndrome
    Liu, Yanmei
    Zhang, Bei
    Lei, Yimeng
    Xia, Liping
    Lu, Jing
    Shen, Hui
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (03) : 374 - 380
  • [33] Interleukin-27 is essential for type 1 diabetes development and Sjogren syndrome-like inflammation (vol 29, 3073, 2019)
    Ciecko, Ashley E.
    Foda, Bardees
    Barr, Jennifer Y.
    Ramanathan, Sheela
    Atkinson, Mark A.
    Serreze, David V.
    Geurts, Aron M.
    Lieberman, Scott M.
    Chen, Yi-Guang
    CELL REPORTS, 2021, 34 (05):
  • [34] Interleukin-27 and interleukin-37 are elevated in sickle cell anemia patients and inhibit in vitro secretion of interleukin-8 in neutrophils and monocytes
    Alagbe, A. E.
    Justo Junior, A. S.
    Ruas, L. P.
    Tonasse, W. V.
    Santana, R. M.
    Batista, T. H. C.
    Domingos, I. F.
    Araujo, A. S.
    Bezerra, M. A. C.
    Santos, M. N. N.
    Blotta, M. H. S. L.
    CYTOKINE, 2018, 107 : 85 - 92
  • [35] THE ASSOCIATION BETWEEN PLASMA INTERLEUKIN-27 (IL-27) LEVELS AND THE SEVERITY OR INSTABLITY OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CAD
    Miura, K.
    Saita, E.
    Suzuki, N.
    Miyata, K.
    Ikemura, N.
    Ohmori, R.
    Ikegami, Y.
    Kishimoto, Y.
    Kondo, K.
    Momiyama, Y.
    ATHEROSCLEROSIS, 2016, 252 : E174 - E175
  • [36] Interleukin-27 in T Cell Immunity
    Iwasaki, Yukiko
    Fujio, Keishi
    Okamura, Tomohisa
    Yamamoto, Kazuhiko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (02) : 2851 - 2863
  • [37] Potent antitumor activity of interleukin-27
    Hisada, M
    Kamiya, S
    Fujita, K
    Belladonna, ML
    Aoki, T
    Koyanagi, Y
    Mizuguchi, J
    Yoshimoto, T
    CANCER RESEARCH, 2004, 64 (03) : 1152 - 1156
  • [38] Interleukin-27 and its relation to disease parameters in SLE patients
    Gaber, Wafaa
    Sayed, Safaa
    Rady, Hanaa M.
    Mohey, Abeer M.
    EGYPTIAN RHEUMATOLOGIST, 2012, 34 (03): : 99 - 105
  • [39] Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients
    Ghahartars, Mehdi
    Najafzadeh, Shiva
    Abtahi, Shabnam
    Fattahi, Mohammad Javad
    Ghaderi, Abbas
    DERMATOLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [40] Interleukin-27: A Master Regulator in Inflammation
    Fearon, Ursula
    ARTHRITIS AND RHEUMATISM, 2011, 63 (08): : 2157 - 2160
12345